The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 04, 2005
Filed:
Dec. 13, 2000
Patricia D. Murphy, Slingerland, NY (US);
Antonette C. Allen, Severn, MD (US);
Christopher P. Alvares, Potomac, MD (US);
Brenda S. Critz, Frederick, MD (US);
Sheri J. Olson, Arlington, VA (US);
Denise B. Schelter, Silver Spring, MD (US);
Bin Zeng, Rockville, MD (US);
Patricia D. Murphy, Slingerland, NY (US);
Antonette C. Allen, Severn, MD (US);
Christopher P. Alvares, Potomac, MD (US);
Brenda S. Critz, Frederick, MD (US);
Sheri J. Olson, Arlington, VA (US);
Denise B. Schelter, Silver Spring, MD (US);
Bin Zeng, Rockville, MD (US);
Gene Logic Inc., Gaithersburg, MD (US);
Abstract
isolated coding sequences and to the protein sequences they code for. This invention is directed to three coding sequence of the BRCA1 gene. The three coding sequences, BRCA1, BRCA1, and BRCA1and their frequencies of occurrence are provided together with the protein sequences they code for. Another aspect of this invention is a method of determining the consensus sequence for any gene. Another aspect of the invention is a method of identifying an individual having an increased genetic susceptibility to breast or ovarian cancer because they have inherited a causative mutation in their BRCA1 gene. This invention is also related to a method of performing gene therapy with any of the isolated BRCA1 coding sequences.